🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. TAP-144-SR(6M)

    Takeda

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

  2. TDV

    Takeda

    Healthy Volunteers

    phase 3 mab completed

    4 trials

  3. TDV

    Takeda

    Dengue Fever

    phase 3 mab active

    5 trials

  4. TED

    Takeda

    Short Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  5. TVP-1012

    Takeda

    Parkinson's Disease

    phase 3 small molecule completed

    1 trial

  6. TVP-1012 1mg

    Takeda

    Parkinson's Disease

    phase 3 small molecule completed

    3 trials

  7. TachoSil®

    Takeda

    Hemorrhage

    phase 3 mab completed

    1 trial

  8. TachoSil®

    Takeda

    Bleeding

    phase 3 small molecule completed

    1 trial

  9. TachoSil®

    Takeda

    Cerebrospinal Fluid Leaks

    phase 3 other completed

    1 trial

  10. Tacrolimus

    Takeda

    Ulcerative Colitis

    phase 3 small molecule terminated

    1 trial

  11. Takeda's Dengue Tetravalent Vaccine (Live, Attenuated) (TDV)

    Takeda

    Dengue Fever

    phase 3 mab completed

    1 trial

  12. Teduglutide

    Takeda

    Short Bowel Syndrome

    phase 3 small molecule active

    13 trials

  13. Teduglutide 0.05mg/kg

    Takeda

    Short Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  14. Tetravalent Dengue Vaccine (TDV)

    Takeda

    Dengue Fever

    phase 3 mab active

    2 trials

  15. Tetravalent Dengue Vaccine (TDV)

    Takeda

    Dengue

    phase 3 mab completed

    1 trial

  16. Trelagliptin 25 mg

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  17. VONVENDI

    Takeda

    Von Willebrand Disease (VWD)

    phase 3 mab active

    1 trial

  18. VPRIV ®,

    Takeda

    Gaucher Disease, Type 1

    phase 3 mab completed

    2 trials

  19. Vedolizumab

    Takeda

    Ulcerative Colitis

    phase 3 small molecule completed

    9 trials

  20. Vedolizumab

    Takeda

    Primary Sclerosing Cholangitis

    phase 3 small molecule terminated

    1 trial

  21. Vedolizumab

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    5 trials

  22. Vedolizumab

    Takeda

    Pouchitis

    phase 3 small molecule active

    1 trial

  23. Vedolizumab 300 mg IV

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  24. Vedolizumab IV

    Takeda

    Crohn's Disease

    phase 3 small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources